The complexity and diversity of major histocompatibility complex challenge disease association studies

Marja-Liisa Lokki, Riitta Paakkanen

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

Originalspråkengelska
TidskriftHLA
Volym93
Utgåva1
Sidor (från-till)3-15
Antal sidor13
ISSN2059-2302
DOI
StatusPublicerad - jan 2019
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

  • 3111 Biomedicinska vetenskaper
  • 1182 Biokemi, cell- och molekylärbiologi

Citera det här

@article{028c5ee0b7d84872b9eccff37fddf248,
title = "The complexity and diversity of major histocompatibility complex challenge disease association studies",
keywords = "association, disease, haplotype, HLA, MHC, populations, SOLUBLE HLA-DR, HIGH-RESOLUTION HLA, CLASS-II PROTEINS, C4 GENE, COMPONENT C4, EXPRESSION, SERUM, RISK, SUSCEPTIBILITY, 3111 Biomedicine, 1182 Biochemistry, cell and molecular biology",
author = "Marja-Liisa Lokki and Riitta Paakkanen",
year = "2019",
month = "1",
doi = "10.1111/tan.13429",
language = "English",
volume = "93",
pages = "3--15",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley",
number = "1",

}

The complexity and diversity of major histocompatibility complex challenge disease association studies. / Lokki, Marja-Liisa; Paakkanen, Riitta.

I: HLA, Vol. 93, Nr. 1, 01.2019, s. 3-15.

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

TY - JOUR

T1 - The complexity and diversity of major histocompatibility complex challenge disease association studies

AU - Lokki, Marja-Liisa

AU - Paakkanen, Riitta

PY - 2019/1

Y1 - 2019/1

KW - association

KW - disease

KW - haplotype

KW - HLA

KW - MHC

KW - populations

KW - SOLUBLE HLA-DR

KW - HIGH-RESOLUTION HLA

KW - CLASS-II PROTEINS

KW - C4 GENE

KW - COMPONENT C4

KW - EXPRESSION

KW - SERUM

KW - RISK

KW - SUSCEPTIBILITY

KW - 3111 Biomedicine

KW - 1182 Biochemistry, cell and molecular biology

U2 - 10.1111/tan.13429

DO - 10.1111/tan.13429

M3 - Review Article

VL - 93

SP - 3

EP - 15

JO - HLA

JF - HLA

SN - 2059-2302

IS - 1

ER -